EE43 Utilizing Real-World Evidence to Estimate Treatment Costs Among Norwegian Patients with Myasthenia Gravis Treated with Intravenous Immunoglobulin (IVIG)
Abstract
Authors
C. Bugge I. Engebretsen I.S. Kristiansen F. Arneberg N.E. Gilhus